MedPath

A ProspectiveTrial Comparing THUNDERBEAT to the Ligasure Energy Device During Laparoscopic Colon Surgery

Not Applicable
Completed
Conditions
Colon Cancer
Interventions
Device: THUNDERBEAT
Device: LIGASURE
Registration Number
NCT02628093
Lead Sponsor
Weill Medical College of Cornell University
Brief Summary

Prospective randomized controlled study, at Colon and Rectal Surgery, WMC/NYPH. Subjects undergoing Laparoscopic Left Colectomy will be randomized into 1 of 2 groups based on the instrument used for tissue dissection and vessel ligation: Group 1 - THUNDERBEAT Group 2

- Ligasure Population

Detailed Description

Prospective randomized controlled study, at Colon and Rectal Surgery, WMC/NYPH. Subjects undergoing Laparoscopic Left Colectomy will be randomized into 1 of 2 groups based on the instrument used for tissue dissection and vessel ligation: Group 1 - THUNDERBEAT Group 2

- Ligasure Population: 60 subjects, with colon neoplasm or diverticulitis will be invited in the study after surgery is deemed necessary Study Procedures: This project will consist only of prospective data collection. No interventions will be done for research purpose. Data will be collected prospectively on: -Patients (before, during and after surgery) -The THUNDERBEAT and LigaSure instruments Data will be collected on data collection sheets and entered in a password protected database Primary Outcomes/Definitions- Overall time for dissection of the soft tissues necessary for specimen removal during colon resection, measured in minutes, from the start of colon mobilization to specimen removal from the abdominal cavity.

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
73
Inclusion Criteria
  • Patients that will be undergoing a Left Laparoscopic Colon Resection
  • Older than 18 years old
  • ASA 1 to 3
  • Elective surgeries
  • Patients who willingly provide informed consent
Read More
Exclusion Criteria
  • Morbidly obese patients (BMI >35)
  • Patients with acute diverticulitis
  • Patients with multiple previous abdominal surgeries
  • Patients on anticoagulants
  • Patients who can not, tolerate a major surgery
  • Patients for whom electrosurgery is contraindicated
  • Patients who are pregnant
  • Patient with IBDs
Read More

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
THUNDERBEATTHUNDERBEATTHUNDERBEAT energy device ( Olympus) will be used for dissection of tissue and ligation of vessels
LIGASURELIGASURELIGASURE energy device will be used for dissection of tissue and ligation of vessels
Primary Outcome Measures
NameTimeMethod
Overall Time for Dissection of the Soft TissuesDay 0 Surgical procedure

from the start of colon mobilization to specimen removal from the abdominal cavity

Versatility ScoreDay 0 Surgical procedure

Total/Composite score (composite of 5 variables:hemostasis;sealing;cutting;dissection;and tissue manipulation) was measured by a score system from 1 to 5 (1 being worst and 5 best) for each of the 5 variables,weighted by Coefficient of Importance with weight distribution as follow: hemostasis 0.275, sealing 0.275, cutting 0.2, dissection 0.15, and tissue Manipulation 0.1.). The final reported score is a weighted average.

Secondary Outcome Measures
NameTimeMethod
Length of Post Surgical Stay in the Hospitalfrom Surgery date to the discharge date from the hospital up to 30 days

Length of post surgical stay in the hospital measured in days

Intraoperative Complication Related to the Energy DevicesDay 0 Surgical procedure

Intraoperative adverse event occurrences during surgery due to the energy devices (THUNDERBEAT and LigaSure) measured as categorical variable "Yes" or "No"

Delayed Thermal Injuries Related to Energy DevicesDAY 1 to DAY 30 Postsurgery

Delayed thermal injuries related to Energy devices that occur after surgery within 30 days of the surgical date, measured as categorical variables "Yes" or "No".

Dryness of the Surgical Field Average Score Mean/sdDay 0 Surgical Procedure

Measured by score from 1 to 5 where 1 means Heavy bleeding , hemostasis achieved with the instrument with more than 2 attempts, and 5 means No oozing at vessel or tissue site in entire surgical field .

Operative Procedure TimeDay 0 Surgical Procedure

operative procedure time measured in minutes from the start of the incision to the last stitch in the closure of the surgical incision

Trial Locations

Locations (1)

Weill Cornell Medical Center- NYPH

🇺🇸

New York, New York, United States

© Copyright 2025. All Rights Reserved by MedPath